Cmed has considerable expertise in the delivery of complex and demanding
clinical trials, including early phase, Proof of Concept, oncology, rare
diseases and adaptive studies. Cmed couples this experience with encapsia®,
a proven new generation clinical data suite already used to successfully
complete studies for both large and small Biopharma companies, to set up
and conduct trials faster, smarter and more efficiently. This unique
combination of operational expertise and the latest technology,
supported by optimized processes, allows Sponsors to collect, query,
clean, visualize and analyze their clinical trial data in ways that were
not possible before.

Cmed will demonstrate how immediate access to real-time clinical data
can support effective and efficient decision making, improve patient
safety, increase productivity and drive data quality while reducing
costs and timelines, at Booth 1359. Attendees will also be able to find
out about Cmed’s full suite of services, which ranges from full service
to stand-alone solutions and functional services.

Cmed is an innovative, full service technology-led CRO. Cmed brings
together experienced people and technology, providing customers with a
friendly, proactive service, and delivers this service using advanced
clinical data capture, management and reporting software and processes.
Cmed’s new generation clinical data suite, encapsia™, streamlines the
capture, management and reporting of clinical data, saving customers
time and money. Clinical data can be captured flexibly by eSource,
multi-media and web eDC, while being displayed in live visual insights,
providing live analytics, and allowing within suite audit trailed
actions. It is fully compliant with regulatory guidelines, and allows
integration with existing systems. For more information visit www.cmedresearch.com.